All patients receiving DDAVP Nasal Spray should be observed for the following signs or symptoms associated with hyponatremia: headache, nausea/vomiting, decreased serum sodium, weight gain, restlessness, fatigue, lethargy, disorientation, depressed reflexes, loss appetite, irritability, muscle weakness, muscle spasms or cramps and abnormal mental status such as hallucinations, decreased consciousness, and confusion
Headache 60 , 12591272 (2020)
ABOUT BRAND: MEDICUBE
(NYSE: ENHA) the elite sports competition and personalized performance products company commended the United States Food & Drug Administrations (FDA) Pharmacy Compounding Advisory Committee (PCAC) for its vote last week recommending that BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax be added to the FDA's Section 503A Bulk Drug Substances List
By influencing sleep architecture, DSIP may indirectly support alignment between neural oscillations and endocrine pulses